This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Biofrontera バランスシートの健全性
財務の健全性 基準チェック /46
主要情報
0.5%
負債資本比率
€100.00k
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | €1.75m |
| エクイティ | €21.28m |
| 負債合計 | €11.33m |
| 総資産 | €32.61m |
財務の健全性に関する最新情報
Recent updates
財務状況分析
短期負債: B8FE's short term assets (€9.3M) do not cover its short term liabilities (€9.8M).
長期負債: B8FE's short term assets (€9.3M) exceed its long term liabilities (€1.6M).
デット・ツー・エクイティの歴史と分析
負債レベル: B8FE has more cash than its total debt.
負債の削減: B8FE's debt to equity ratio has reduced from 58% to 0.5% over the past 5 years.
債務返済能力: B8FE's debt is well covered by operating cash flow (33421%).
インタレストカバレッジ: Insufficient data to determine if B8FE's interest payments on its debt are well covered by EBIT.